XOMA Royalty Corp. Files 2024 Annual Report
Ticker: XOMAP · Form: 10-K · Filed: Mar 17, 2025 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Royalty Corp (XOMAP) |
| Form Type | 10-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
TL;DR
XOMA Royalty Corp. dropped its 2024 10-K. Check financials and strategy.
AI Summary
XOMA Royalty Corp. filed its 2024 10-K on March 17, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, formerly known as XOMA Corp, is in the pharmaceutical preparations industry. Key financial details and operational highlights for 2024 are presented in this annual report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of XOMA Royalty Corp.'s financial health, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, XOMA Royalty Corp. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-17 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- XOMA Royalty Corp. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-17 (date) — Filing date
- XOMA Corp (company) — Former company name
- 2200 Powell Street, Suite 310, Emeryville, CA 94608 (address) — Company business and mailing address
- 510-204-7239 (phone_number) — Company business phone
- Talphera (company) — Mentioned in relation to commercial payment purchase agreement
- U.S. Department of Defense (organization) — Customer mentioned in relation to Talphera
FAQ
What were XOMA Royalty Corp.'s primary revenue streams in 2024?
The filing does not explicitly detail primary revenue streams in the provided snippet, but mentions a 'CommercialPaymentPurchaseAgreement' with Talphera on January 12, 2024.
Did XOMA Royalty Corp. undergo any significant corporate name changes recently?
Yes, the company was formerly known as XOMA Corp, with a name change date of January 19, 2012.
What is XOMA Royalty Corp.'s Standard Industrial Classification (SIC) code?
XOMA Royalty Corp.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's primary business address?
The company's business address is 2200 Powell Street, Suite 310, Emeryville, CA 94608.
Are there any specific agreements mentioned with government entities?
Yes, a 'CommercialPaymentPurchaseAgreement' is mentioned with the 'U.S. Department of Defense' in relation to Talphera on January 12, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding XOMA Royalty Corp (XOMAP).